What Are the Challenges in Targeting Proliferative Signaling?
One major challenge is the heterogeneity of cancer, where different cells within the same tumor may rely on distinct proliferative signals. Additionally, cancer cells can develop resistance to targeted therapies through mutations, activation of alternative pathways, or feedback mechanisms that restore signaling. Therefore, understanding the specific signaling dependencies of individual tumors is crucial for effective treatment.
